Variables | Bivariable analysis | Multivariable analysis | ||
---|---|---|---|---|
HR (95% CI) | p value | aHR (95% CI) | p value | |
SAPS2 > 43 | 1.76 (1.03–3.00) | 0.038 | 1.93 (1.12–3.34) | 0.018 |
Chronic pulmonary disease | 1.68 (0.93–3.04) | 0.086 | – | |
Liver cirrhosis | 1.89 (0.86–4.17) | 0.11 | – | |
Ab < 3 mo., broad-sp. > 10 d | 2.21 (1.31–3.71) | 0.003 | – | |
C3G < 3 mo | 1.64 (0.93–2.90) | 0.087 | – | |
Carbapenem < 3 mo | 2.59 (1.11–6.06) | 0.03 | – | |
Charlson > 2 | 1.75 (1.04–2.95) | 0.034 | – | |
ESBL colonization at admission | 1.56 (0.92–2.63) | 0.10 | – | |
Septic shock associated with nosocomial pneumonia | 2.86 (1.68–4.85) | 0.0001 | 2.81 (1.66–4.78) | <0.0001 |
VAP | 0.48 (0.24–0.96) | 0.037 | 0.48 (0.24–0.98) | 0.04 |
ESBL-PE ICUAP | 1.57 (0.93–2.64) | 0.091 | 1.15 (0.65–2.05) | 0.64 |
ICU-acquired infection before ICUAP | 0.51 (0.28–0.95) | 0.033 | 0.52 (0.28–0.97) | 0.04 |
Others antibiotics between colonization and pneumonia | 1.49 (0.89–2.52) | 0.13 | – | |
Appropriate empirical antimicrobial therapya | 1.05 (0.56–1.95) | 0.88 | 0.66 (0.34–1.27) | 0.22 |